Insmed Incorporated
INSM
$68.12
$0.901.34%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Revenue | 381.03M | 363.71M | 342.96M | 328.61M | 315.49M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 381.03M | 363.71M | 342.96M | 328.61M | 315.49M |
| Cost of Revenue | 89.56M | 85.74M | 78.03M | 73.57M | 69.20M |
| Gross Profit | 291.47M | 277.97M | 264.92M | 255.04M | 246.29M |
| SG&A Expenses | 515.56M | 461.12M | 408.13M | 379.83M | 357.69M |
| Depreciation & Amortization | 5.05M | 5.05M | 5.05M | 5.05M | 5.05M |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 1.24B | 1.15B | 1.05B | 972.46M | 996.17M |
| Operating Income | -859.01M | -786.57M | -703.93M | -643.85M | -680.68M |
| Income Before Tax | -1.01B | -910.07M | -860.85M | -799.73M | -744.23M |
| Income Tax Expenses | 4.03M | 3.71M | 3.44M | 2.97M | 2.66M |
| Earnings from Continuing Operations | -1.01K | -913.77 | -864.29 | -802.69 | -746.89 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -1.01B | -913.77M | -864.29M | -802.69M | -746.89M |
| EBIT | -859.01M | -786.57M | -703.93M | -643.85M | -680.68M |
| EBITDA | -849.84M | -777.70M | -695.06M | -634.95M | -671.90M |
| EPS Basic | -5.95 | -5.59 | -5.56 | -5.40 | -5.24 |
| Normalized Basic EPS | -3.22 | -3.11 | -2.97 | -2.89 | -3.14 |
| EPS Diluted | -5.95 | -5.59 | -5.56 | -5.40 | -5.24 |
| Normalized Diluted EPS | -3.22 | -3.11 | -2.97 | -2.89 | -3.14 |
| Average Basic Shares Outstanding | 688.30M | 655.90M | 621.69M | 590.86M | 573.71M |
| Average Diluted Shares Outstanding | 688.30M | 655.90M | 621.69M | 590.86M | 573.71M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |